Concepedia

Ludovicus Staelens

LS

20

Publications

894

Citations

14

H-Index

2004

Active since

Affiliations

UCB Pharma (Belgium)(Current)

Ghent University

Ghent University Hospital

University of Liège

Bristol-Myers Squibb (United States)

Ludovicus Staelens is an author at UCB Pharma (Belgium) specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

2004–2022

20

Publications

20

Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis

Ken Coppieters, Torsten Dreier, Karen Silence et al. · Arthritis & Rheumatism · 2006 · 296 citations

Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (<scp>SV</scp>2A) ligand with preclinical evidence of high brain permeability and fast onset of action

Jean‐Marie Nicolas, Jonas Hannestad, Daniel Holden et al. · Epilepsia · 2015 · 159 citations · Full text

In-Depth Study of Homogeneity in DBS Using Two Different Techniques: Results from The EBF DBS-Microsampling Consortium

Zoe Cobb, Ronald de Vries, Neil Spooner et al. · Bioanalysis · 2013 · 64 citations

Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions

Omar Qureshi, Tania F. Rowley, Fabian Junker et al. · Scientific Reports · 2017 · 47 citations · Full text

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)

An Song, Anita Lee, Fabio Garofolo et al. · Bioanalysis · 2016 · 42 citations · Full text

Rows per page

1–5 of 20